|
ATE384128T1
(de)
*
|
1998-03-12 |
2008-02-15 |
Astellas Pharma Inc |
Neue g protein-gekoppelte rezeptorproteine
|
|
US6071722A
(en)
*
|
1998-04-24 |
2000-06-06 |
Smithkline Beecham Corporation |
Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
|
|
JP2002512780A
(ja)
*
|
1998-04-24 |
2002-05-08 |
スミスクライン ビーチャム コーポレーション |
新規７ｔｍ受容体ａｘｏｒ−２のクローニング
|
|
EP1155031A4
(en)
*
|
1998-11-03 |
2002-11-27 |
Smithkline Beecham Corp |
G PROTEIN TORQUE RECEPTOR, SAID AXOR-14
|
|
US20030017528A1
(en)
|
1998-11-20 |
2003-01-23 |
Ruoping Chen |
Human orphan G protein-coupled receptors
|
|
USRE42190E1
(en)
|
1998-11-20 |
2011-03-01 |
Arena Pharmaceuticals, Inc. |
Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
|
|
US7816492B2
(en)
|
1998-11-20 |
2010-10-19 |
Arena Pharmaceuticals, Inc. |
Human G protein-coupled receptors
|
|
US6221660B1
(en)
|
1999-02-22 |
2001-04-24 |
Synaptic Pharmaceutical Corporation |
DNA encoding SNORF25 receptor
|
|
EP1157038A4
(en)
*
|
1999-02-26 |
2005-01-19 |
Smithkline Beecham Corp |
CLONING OF A P2Y-LIKE 7TM RECEPTOR (AXOR17)
|
|
US6620615B1
(en)
*
|
1999-04-23 |
2003-09-16 |
Curagen Corporation |
G-protein coupled receptor—encoding nucleic acids
|
|
WO2000078809A1
(en)
*
|
1999-06-21 |
2000-12-28 |
Smithkline Beecham Corporation |
Axor16, a g protein coupled receptor
|
|
WO2001004292A1
(en)
*
|
1999-07-13 |
2001-01-18 |
Merck Patent Gmbh |
G-protein coupled receptor and dna sequences thereof
|
|
CA2381437A1
(en)
*
|
1999-07-30 |
2001-02-08 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
G-protein coupled receptor and dna sequences thereof
|
|
EP1207169A4
(en)
*
|
1999-08-27 |
2003-03-19 |
Takeda Chemical Industries Ltd |
NOVEL G PROTEIN COUPLED RECEPTOR PROTEIN AND ITS DNA
|
|
US6998255B1
(en)
|
1999-09-24 |
2006-02-14 |
Solvay Pharmaceuticals B.V. |
Human G-protein coupled receptor
|
|
GB9923177D0
(en)
*
|
1999-09-30 |
1999-12-01 |
Pfizer Ltd |
Novel polypeptide
|
|
US6204017B1
(en)
|
1999-10-07 |
2001-03-20 |
Schering Corporation |
Polynucleotide encoding a histamine receptor
|
|
GB9923893D0
(en)
*
|
1999-10-08 |
1999-12-08 |
Pfizer Ltd |
Novel polypeptide
|
|
GB9923890D0
(en)
*
|
1999-10-08 |
1999-12-08 |
Pfizer Ltd |
Novel polypeptide
|
|
GB9924960D0
(en)
*
|
1999-10-21 |
1999-12-22 |
Pfizer Ltd |
Novel polypeptide
|
|
GB9924956D0
(en)
*
|
1999-10-21 |
1999-12-22 |
Pfizer Ltd |
Novel polypeptide
|
|
AU1575601A
(en)
*
|
1999-10-27 |
2001-05-08 |
Pharmacia & Upjohn Company |
G protein-coupled receptors expressed in brain
|
|
EP1096009B1
(en)
*
|
1999-10-29 |
2007-10-10 |
Pfizer Limited |
G-protein coupled receptor-like Polypeptide
|
|
EP1226250A2
(en)
*
|
1999-11-03 |
2002-07-31 |
MERCK PATENT GmbH |
Gpcr-kd5 polypeptides and dna sequences thereof
|
|
US6461836B1
(en)
|
1999-11-05 |
2002-10-08 |
Smithkline Beecham Corporation |
Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof
|
|
WO2001036473A2
(en)
*
|
1999-11-16 |
2001-05-25 |
Pharmacia & Upjohn Company |
Human g protein-coupled receptors
|
|
US7029857B1
(en)
|
1999-12-17 |
2006-04-18 |
H. Lundbeck A/S |
Processes for obtaining compounds employing SNORF72 receptors
|
|
AU2398501A
(en)
*
|
1999-12-20 |
2001-07-03 |
Banyu Pharmaceutical Co., Ltd. |
Novel guanosine triphosphate-binding protein-coupled receptor protein, bg26
|
|
CA2395416A1
(en)
|
1999-12-23 |
2001-06-28 |
Millennium Pharmaceuticals, Inc. |
P2y12 receptor
|
|
WO2001048189A1
(fr)
*
|
1999-12-28 |
2001-07-05 |
Helix Research Institute |
Nouveaux recepteurs couples a une proteine de liaison au guanosine triphosphate, genes de ces derniers, et production et utilisation de ces derniers
|
|
GB0001700D0
(en)
*
|
2000-01-25 |
2000-03-15 |
Glaxo Group Ltd |
Novel protein
|
|
IL150824A0
(en)
|
2000-02-04 |
2003-02-12 |
Takeda Chemical Industries Ltd |
Screening method
|
|
EP1266005B1
(en)
*
|
2000-03-14 |
2007-03-07 |
Bayer HealthCare AG |
Regulation of human lipoxin a4 receptor-like protein
|
|
AU3930201A
(en)
*
|
2000-03-17 |
2001-09-24 |
Bayer Aktiengesellschaft |
Regulation of human leukotriene B4-like G protein-coupled receptor
|
|
AU2001241156A1
(en)
*
|
2000-03-21 |
2001-10-03 |
Yamanouchi Pharmaceutical Co..Ltd. |
Novel leukotriene b4 receptor
|
|
WO2001073021A1
(fr)
*
|
2000-03-28 |
2001-10-04 |
Takeda Chemical Industries, Ltd. |
Nouvelle proteine receptrice couplee a une proteine g et adn associe
|
|
WO2001073023A1
(fr)
*
|
2000-03-31 |
2001-10-04 |
Helix Research Institute |
Nouveau recepteur gprv53 couple a une proteine se liant a la guanosine-triphosphate, gene correspondant et procede de production et d'utilisation associe
|
|
AU2001248755A1
(en)
*
|
2000-04-12 |
2001-10-23 |
Takeda Chemical Industries Ltd. |
Novel g protein-coupled receptor protein and dna thereof
|
|
EP1178110A1
(en)
*
|
2000-08-01 |
2002-02-06 |
Aventis Pharma Deutschland GmbH |
EDG8 receptor for sphingosine 1-phosphate , its preparation and use
|
|
EP1287133B1
(en)
*
|
2000-05-18 |
2006-12-13 |
Bayer HealthCare AG |
Regulation of human dopamine-like g protein-coupled receptor
|
|
AU2001276837A1
(en)
*
|
2000-06-23 |
2002-01-08 |
Tularik, Inc. |
Human and mouse g-protein couipled receptors
|
|
WO2002000725A2
(en)
*
|
2000-06-26 |
2002-01-03 |
Akzo Nobel N.V. |
G-protein coupled receptor org10
|
|
WO2002002599A2
(en)
*
|
2000-06-30 |
2002-01-10 |
Ingenium Pharmaceuticals Ag |
HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF
|
|
AU2001271838A1
(en)
*
|
2000-07-06 |
2002-01-21 |
Bayer Corporation |
Human neuropeptide y-like g protein-coupled receptor
|
|
WO2002012344A2
(en)
*
|
2000-08-09 |
2002-02-14 |
Millennium Pharmaceuticals, Inc. |
Methods for using 14266, a human g protein-coupled receptor
|
|
US6790608B2
(en)
*
|
2000-09-20 |
2004-09-14 |
The Regents Of The University Of California |
Methods of identifying and ADP-glucose receptor ligand, agonist or antagonist
|
|
AU2002210982A1
(en)
*
|
2000-11-01 |
2002-05-15 |
Yamanouchi Pharmaceutical Co..Ltd. |
Method of screening antiplatelet
|
|
CA2426037A1
(en)
*
|
2000-11-07 |
2002-05-16 |
Paradigm Therapeutics Limited |
A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
|
|
EP1364024A2
(en)
*
|
2000-11-27 |
2003-11-26 |
Arena Pharmaceuticals, Inc. |
Endogenous and non-endogenous versions of human g protein-coupled receptors
|
|
EP1338651B9
(en)
|
2000-12-01 |
2007-05-09 |
Astellas Pharma Inc. |
Method of screening remedy for diabetes
|
|
AU2002246680A1
(en)
|
2000-12-22 |
2002-07-30 |
University Of South Florida |
Sphingosine 1-phosphate receptor gene, sppr
|
|
US20020155473A1
(en)
*
|
2000-12-22 |
2002-10-24 |
Zaoyuan Peng |
Methods for identifying G-protein coupled receptors associated with diseases
|
|
GB0100782D0
(en)
*
|
2001-01-11 |
2001-02-21 |
Glaxo Group Ltd |
Assay
|
|
JPWO2002088355A1
(ja)
*
|
2001-04-25 |
2004-08-19 |
藤沢薬品工業株式会社 |
新規なグアノシン三リン酸結合タンパク質共役型の受容体ｐｌａｃｅ６００２３１２およびその遺伝子、並びにそれらの製造および用途
|
|
US7419658B2
(en)
|
2001-07-09 |
2008-09-02 |
Euroscreen S.A. |
Isolated ligand of ChemerinR
|
|
US20030096299A1
(en)
|
2001-07-09 |
2003-05-22 |
Valerie Wittamer |
Natural ligand of G protein coupled receptor ChemR23 and uses thereof
|
|
US7858755B2
(en)
|
2001-07-09 |
2010-12-28 |
Euroscreen S.A. |
Monoclonal antibodies that bind Chemerin polypeptide
|
|
US6946244B2
(en)
*
|
2001-08-07 |
2005-09-20 |
Euroscreen, S.A. |
Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13)
|
|
MXPA04009959A
(es)
|
2002-04-12 |
2004-12-13 |
Schering Corp |
Ligandos del receptor acoplado a la proteina g y metodos.
|
|
WO2004022086A1
(ja)
*
|
2002-09-02 |
2004-03-18 |
Takeda Pharmaceutical Company Limited |
副腎皮質ホルモン分泌調節剤
|
|
CA2487854A1
(en)
*
|
2002-10-11 |
2004-04-22 |
Yamanouchi Pharmaceutical Co., Ltd. |
Method for screening an agent for treating renal failure
|
|
US7056685B1
(en)
|
2002-11-05 |
2006-06-06 |
Amgen Inc. |
Receptor ligands and methods of modulating receptors
|
|
DE60335827D1
(de)
|
2002-12-20 |
2011-03-03 |
Merck Sharp & Dohme |
1-(amino)indane als edg-rezeptoragonisten
|
|
MXPA05007485A
(es)
|
2003-01-14 |
2006-01-30 |
Arena Pharm Inc |
Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
|
|
US7083933B1
(en)
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
|
JP2007526747A
(ja)
*
|
2003-06-27 |
2007-09-20 |
タノックス インコーポレーテッド |
ヒトマスト細胞発現膜タンパク質
|
|
US7524638B1
(en)
|
2003-06-27 |
2009-04-28 |
Osi Pharmaceuticals, Inc. |
Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease
|
|
DOP2006000008A
(es)
*
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
|
GB0508990D0
(en)
*
|
2005-05-03 |
2005-06-08 |
Novartis Ag |
Organic compounds
|
|
US7833730B2
(en)
|
2006-04-11 |
2010-11-16 |
Arena Pharmaceuticals, Inc. |
Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
|
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
|
AU2008279447A1
(en)
|
2007-07-19 |
2009-01-29 |
Metabolex, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
|
|
BRPI0817211A2
(pt)
|
2007-09-20 |
2017-05-16 |
Irm Llc |
composto composições como moduladores da atividade de gpr119
|
|
EP2108960A1
(en)
|
2008-04-07 |
2009-10-14 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
|
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
|
JP5909185B2
(ja)
|
2009-10-01 |
2016-04-26 |
シマベイ セラピューティクス， インコーポレーテッド |
置換テトラゾール−１−イルフェノキシメチルチアゾール−２−イルピペリジニルピリミジン塩
|
|
US8791100B2
(en)
|
2010-02-02 |
2014-07-29 |
Novartis Ag |
Aryl benzylamine compounds
|
|
CA2795513A1
(en)
|
2010-04-06 |
2011-10-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
JP5847813B2
(ja)
|
2010-06-23 |
2016-01-27 |
シマベイ セラピューティクス， インコーポレーテッド |
５−エチル−２−｛４−［４−（４−テトラゾル−１−イル−フェノキシメチル）−チアゾール−２−イル］−ピペリジン−１−イル｝−ピリミジンの組成物
|
|
EP3323818A1
(en)
|
2010-09-22 |
2018-05-23 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
US20140018371A1
(en)
|
2011-04-01 |
2014-01-16 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
|
WO2012145361A1
(en)
|
2011-04-19 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
US20140038889A1
(en)
|
2011-04-22 |
2014-02-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
|
US20140051714A1
(en)
|
2011-04-22 |
2014-02-20 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
|
WO2012170702A1
(en)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
WO2014074668A1
(en)
|
2012-11-08 |
2014-05-15 |
Arena Pharmaceuticals, Inc. |
Modulators of gpr119 and the treatment of disorders related thereto
|
|
PL3242666T3
(pl)
|
2015-01-06 |
2025-02-17 |
Arena Pharmaceuticals, Inc. |
Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
|
|
BR112017027656B1
(pt)
|
2015-06-22 |
2023-12-05 |
Arena Pharmaceuticals, Inc. |
Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
|
|
AU2017305392A1
(en)
|
2016-08-03 |
2019-02-21 |
Cymabay Therapeutics, Inc. |
Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
|
|
US20200129511A1
(en)
|
2017-06-19 |
2020-04-30 |
Arena Pharmaceuticals, Inc. |
Compounds and methods for treatment of nafld and nash
|
|
CA3102136A1
(en)
|
2018-06-06 |
2019-12-12 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|